The Effect of Antiserum Fractions on Ehrlich Ascites Tumour Cells

Hyperimmune heterologous serum produced in sheep against mouse Ehrlich ascites tumour cells was absorbed with normal mouse tissue and fractionated by DEAE column chromatography into IgG1 and IgG2 fractions. in vitro cytotoxicity test showed that sheep anti-Ehrlich ascites tumour IgGl fraction was cytotoxic to 51Cr labelled tumour cells whereas IgG2 had no cytotoxic effect. Pretreatment of the tumour cells with the non-cytotoxic IgG2 fraction slightly inhibited the cytotoxic action of IgG1 in vitro.When EAT cells were coated with either IgG1 or IgG2 by preincubation in vitro before injecting intraperitoneally into mice, both fractions protected the animals against tumour growth. Injection of IgG2 and IgGl fractions separately, one before and the other after the injection of EAT cells, resulted in partial protection only. The difference encountered between the in vitro and in vivo findings could be attributed to the host defence mechanisms involved in the in vivo test system.

• Publication year

  1971

• Venue

  British Journal of Cancer

• Publication date

  1971-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/bjc.1971.41PMID 5115831PMCID 2008461
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunocytochemical localization of the ovine immunoglobulins IgA, IgG1, IgG1-A and IgG2: effect of gastro-intestinal parasitism in the sheep.

  1971cited by this paper
• Regulation of immunity toward allogeneic tumors in mice. I. Effect of antiserum fractions on tumor growth.

  1969cited by this paper
• Structural Relationship and Complement Fixing Activity of Sheep and other Ruminant Immunoglobulin G Subclasses

  1969cited by this paper
• Immunologic enhancement of tumor xenografts by pepsin-degraded immunoglobulin.

  1969cited by this paper
• Immunization of Mice against Ehrlich Ascites Tumour using a Hamster/Ehrlich Ascites Tumour Hybrid Cell Line

  1969cited by this paper
• Immunological enhancement by mouse isoantibodies: the importance of complement fixation.

  1968cited by this paper
• Immune responses of mice to iodoacetate-treated Ehrlich ascites tumour cells.

  1967cited by this paper
• Separation of 7S gamma-1-globulin, 7S gamma-2-globulin and macroglobulin guinea pig antibodies.

  1966cited by this paper
• Transplantation Immunity : Localization in Mouse Serum of Antibodies Responsible for Haemagglutination, Cytotoxicity and Enhancement

  1966cited by this paper
• Induction of Tumour Immunity with Tumour Cells Treated with Iodoacetate

  1966cited by this paper
• Recovery with immunity after serial tapping of transplantable mouse ascites tumours.

  1966cited by this paper
• QUANTITATIVE TITRATIONS OF MOUSE H‐2 ANTIBODIES USING Cr51‐LABELLED TARGET CELLS

  1965cited by this paper
• PROPERTIES OF GUINEA PIG 7S ANTIBODIES

  1963cited by this paper
• PROPERTIES OF GUINEA PIG 7S ANTIBODIES

  1963cited by this paper
• Transplantation

  1963cited by this paper

• Comparison between the effects of Micrococcus lysodeikticus, bacterial cell wall and related polysaccharides in the nonspecific tumour immunotherapy of Ehrlich ascites tumour growth.

  1979cites this paper
• Parameters of serum complement in relation to tumor therapy.

  1974cites this paper
• The measurement and manipulation of hemolytic complement levels in tumor bearing C57BL/6 mice.

  1973cites this paper
• Passive administration of antiserum and complement in producing anti-EL4 cytotoxic activity in the serum of C57BL-6 mice.

  1973cites this paper
• Augmentation of antitumor antisera activity by lyophilization.

  1973cites this paper
• Depression of complement activity in three strains of mice after tumor transfer

  1973cites this paper